Loading quotes...

Forecast

There is no analyst data available for this company.

News Go to news feed

UnitedHealth raises full-year outlook after better-than-expected Q3, analysts reiterate buy

UnitedHealth reported stronger-than-expected third-quarter results and raised its full-year earnings outlook, citing progress in its turnaround plan and improved Medicare Advantage/Optum Health performance. Morgan Stanley analyst Erin Wright reiterated a buy rating and lifted 2026 and 2027 EPS estimates, noting a lower medical loss ratio and management's view that 2027 consensus is conservative. Analysts see continued operational improvement and upside to long-term EPS targets despite planned incremental investments in Q4. » More on cnbc.com
UnitedHealth rises after stronger quarterly results and nears 100-day line

UnitedHealth jumps significantly after unexpectedly good quarterly results and the outlook given, ranking among the top winners in the Dow Jones. The stock cleared the 50-day line and is trading intraday toward the 100-day line at $397.14, with the year high at $446. The expected P/E ratio for 2027 of 17 appears moderate compared with the ten-year average of 21 and leaves room for further price gains. » More on deraktionaer.de
UnitedHealth raises full-year target for adjusted earnings per share again

UnitedHealth beat expectations in the third quarter and raised its forecast for adjusted earnings per share to at least $20.50. Adjusted EPS rose to $4.69 for the quarter, and net income grew 75% to $4.1 billion. Reasons include a lower share of medical expenses in premium revenue and the reversal of a $610 million reserve. Revenue fell slightly to $112.7 billion; CEO Stephen Hemsley pursued a shrinkage strategy after his return. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2026, UnitedHealth Group Inc has already paid €0.20 in dividends. The last payout was in September.

Financials

In the last quarter, UnitedHealth Group Inc had revenue of €100.4bn and net profit of €3.66bn

(EUR)	September 2026	YoY
Revenue	100.4bn	4.12%
Gross profit	100.4bn	470.92%
Net profit	3.66bn	83.00%
EBITDA	6.73bn	48.20%

Fundamentals

Metric	Value
Market capitalization	€319.84bn
Number of shares	25.98bn
52-week high/low	€18.17 - €7.02
Dividend yield	2.16%
Dividends TTM	€0.26
Beta	0.43
P/E ratio	24.18
PEG ratio	-2.70
P/B ratio	3.67
P/S ratio	0.85

Company profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.